Lawsonia intracellularis vaccine
The present invention relates i.a. to nucleic acid sequences encoding novel Lawsonia intracellularis proteins. It furthermore relates to DNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Also it relates to host cells comprising such nucleic acid sequences, DNA fragments, recombinant DNA molecules and live recombinant carriers. Moreover, the invention relates to proteins encoded by these nucleotide sequences. The invention also relates to vaccines for combating Lawsonia intracellularis infections and methods for the preparation thereof. Finally the invention relates to diagnostic tests for the detection of Lawsonia intracellularis DNA, the detection of Lawsonia intracellularis antigens and of antibodies against Lawsonia intracellularis.
1. An isolated and purified Lawsonia intracellularis outer membrane protein, comprising the amino acid sequence as set forth in SEQ ID NO: 2 and having a molecular weight of about 37 kD as determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis.
2. An immunogenic composition comprising an immunogenically effective amount of the protein according to claim 1 , and a pharmaceutically acceptable carrier.
3. An immunogenic composition according to claim 2 , further comprising an adjuvant.
4. The immunogenic composition according to claim 2 , further comprising at least one antigen in addition to the Lawsonia intracellularis outer membrane protein obtained from a virus or micro-organism pathogenic to pigs.
5. The immunogenic composition according to claim 4 , wherein said virus or micro-organism pathogenic to pigs is selected from the group consisting of Pseudorabies virus, Porcine influenza virus, Porcine parvo virus, Transmissible gastro-enteritis virus, Rotavirus, Escherichia coli, Erysipelo rhusiopathiae, Bordetella bronchiseptica, Salmonella cholerasuis, Haemophilus parasuis, Pasteurella multocida, Streptococcus suis, Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae.